ASND: Ascendis Pharma A/S insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 0 sales totaling - in the last 180 days.

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-13Fell below 5%Artisan Partners Asset Management Inc.4.20%SEC

Institutional ownership (Q2 2026)

304 institutions reported holding $15.47B of Ascendis Pharma A/S on Form 13F (8 the quarter before). 293 opened a new position and 1 sold out. Shares held by institutions: +736%.

Largest holdersSharesValue
RA CAPITAL MANAGEMENT, L.P.10,281,496$2.74B
Avoro Capital Advisors LLC5,111,111$1.36B
WESTFIELD CAPITAL MANAGEMENT CO LP4,798,267$1.28B
Jupiter Topco LLC3,648,772$973.38M
FMR LLC3,545,575$945.68M
Artisan Partners Limited Partnership2,634,024$702.55M
BlackRock, Inc.2,211,833$589.94M
Capital International Investors1,988,614$530.40M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1,875,301$500.14M
FRANKLIN RESOURCES INC1,862,503$496.77M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.